Table 1

Clinical characteristics of the study cohort at admission to hospital and outcomes

VariablesTotal (n=4645)
Men3386 (72.9)
Women1259 (27.1)
Age (mean, years)45.9±18.0
Age groups
<301125 (24.2)
30–491397 (30.1)
50–691650 (35.5)
70+473 (10.2)
Family members/house
1–42395 (51.2)
5–92000 (42.8)
≥10281 (6.0)
Educational status
Illiterate or up to primary education1424 (30.5)
Secondary school and/or higher secondary education1538 (32.9)
Some college1667 (35.7)
Tobacco or smoking (ever)1369 (29.5)
Medical comorbidities1335 (28.6)
Hypertension831 (17.8)
Pulmonary disease193 (4.1)
Type 2 diabetes777 (16.6)
Thyroid disease38 (0.8)
Heart disease75 (1.6)
Neurological disease15 (0.3)
Current or past tuberculosis106 (2.3)
Duration of symptoms at admission (days)
Clinical findings
Pulse rate/min83.9±11.4
Systolic BP mm Hg125.4±12.2
Diastolic BP mm Hg82.8±8.1
Respiratory rate/min19.0±3.7
SpO2 at admission
≥95%2144 (70.0)
90%–94%561 (18.3)
<90%357 (11.7)
Laboratory Investigations (biochemistry n=867; haematology n=4456)
Creatinine, mg/dL0.95+0.50
SGOT, IU44.9±96.5
SGPT, IU43.4±56.2
Sodium, mEq/L136.1±12.5
Potassium, mEq/L5.4±1.1
Haemoglobin (gm/dL)12.7±2.3
White cells (109 cells/L)7527±3830
Lymphocytes (109 cells/L)1589±1325
Lymphocyte/neutrophil ratio0.36±0.32
Outcome measures
Mean duration of hospital stay (days)6.8±3.7
Oxygen requirement861 (18.4)
High flow O2/non-invasive ventilation334 (7.1)
Mechanical ventilation169 (3.6)
Recovered4217 (90.2)
Referred119 (2.5)
Deaths340 (7.3)
  • Numbers ± indicate 1 SD; Numbers in parentheses are percent.

  • BP, blood pressure; SGOT, serum glutamic oxalate transferase; SGPT, serum glutamic pyruvate transferase; SpO2, saturation of peripheral oxygen.